Skip to main content
. 2022 Dec 26;14:195. doi: 10.1186/s13098-022-00970-2

Fig. 2.

Fig. 2

Risk of cardiac arrhythmias in patients randomized to GLP-1 RAs treatment compared with controls across all trials. GLP-1 RAs glucagon-like peptide 1 receptor agonists, CI confidence interval